High insulin prices spur a federal lawsuit against three pharmacy benefit managers

Associated Press

Oct 7

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.

Read the article

Anti-CompetitionPBMsDrug pricingFTCFormulariesInvestigationsCVS CaremarkExpress ScriptsOptumRxInsulinInflationRebates

St. Paul Corner Drug (SPCD)

High insulin prices spur a federal lawsuit against three pharmacy benefit managers

The Pharmacists Fight Back Act

Legalized Racketeering? How PBMs Skirt the Law to Rake in Billions

St. Paul Corner Drug